Gosselies (Wallonia, Belgium), September 19, 2022 – 7:30 a.m. CEST — TheraVet (ISIN code: BE0974387194 – mnemonic: ALVET), a pioneering biotechnology company in the treatment of osteoarticular diseases in pets, today announces its participation in the congress annual meeting of the European Society of Veterinary Orthopedics and Traumatology (ESVOT) which will be held from September 21 to 24 at the Acropolis in Nice (France).
With nearly 1,000 participants, this event is the largest congress specializing in veterinary orthopedics and traumatology in Europe, bringing together high-quality international speakers and therefore represents a showcase of choice for the Company. ESVOT is chaired by Prof. Marc Balligand, who is also Chairman of the Scientific Advisory Board of TheraVet.